Ilse Kern

1.0k total citations
19 papers, 441 citations indexed

About

Ilse Kern is a scholar working on Molecular Biology, Clinical Biochemistry and Surgery. According to data from OpenAlex, Ilse Kern has authored 19 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Clinical Biochemistry and 3 papers in Surgery. Recurrent topics in Ilse Kern's work include Metabolism and Genetic Disorders (7 papers), Mitochondrial Function and Pathology (5 papers) and Amino Acid Enzymes and Metabolism (3 papers). Ilse Kern is often cited by papers focused on Metabolism and Genetic Disorders (7 papers), Mitochondrial Function and Pathology (5 papers) and Amino Acid Enzymes and Metabolism (3 papers). Ilse Kern collaborates with scholars based in Switzerland, United States and Germany. Ilse Kern's co-authors include Bernard Mach, Viktor Steimle, Claire‐Anne Siegrist, Joël Fluss, Martina Huemer, Matthias R. Baumgartner, Karine Hadaya, Brian Fowler, Sabine Scholl‐Bürgi and Ronny Beer and has published in prestigious journals such as PEDIATRICS, Journal of Neurology Neurosurgery & Psychiatry and Journal of Alzheimer s Disease.

In The Last Decade

Ilse Kern

19 papers receiving 434 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ilse Kern Switzerland 10 169 138 101 87 78 19 441
Ubaldo Caruso Italy 15 349 2.1× 338 2.4× 39 0.4× 136 1.6× 150 1.9× 21 662
Yehani Wedatilake United Kingdom 10 329 1.9× 187 1.4× 50 0.5× 41 0.5× 68 0.9× 18 570
Margot F. Mulder Netherlands 13 238 1.4× 147 1.1× 18 0.2× 143 1.6× 48 0.6× 16 540
Katalin Komlósi Hungary 15 235 1.4× 71 0.5× 22 0.2× 64 0.7× 51 0.7× 56 566
John Fernandes Netherlands 11 179 1.1× 205 1.5× 48 0.5× 164 1.9× 268 3.4× 16 631
Ane Cláudia Fernandes Nunes United States 13 127 0.8× 25 0.2× 24 0.2× 90 1.0× 41 0.5× 25 546
Toshihiko Nishino Japan 11 234 1.4× 80 0.6× 171 1.7× 27 0.3× 15 0.2× 15 610
Ilham Ratbi Morocco 15 332 2.0× 65 0.5× 27 0.3× 24 0.3× 78 1.0× 45 617
Silvia Berra Italy 10 178 1.1× 15 0.1× 89 0.9× 32 0.4× 35 0.4× 21 529
Beata S. Lipska‐Ziętkiewicz Poland 13 254 1.5× 23 0.2× 21 0.2× 40 0.5× 41 0.5× 41 538

Countries citing papers authored by Ilse Kern

Since Specialization
Citations

This map shows the geographic impact of Ilse Kern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilse Kern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilse Kern more than expected).

Fields of papers citing papers by Ilse Kern

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ilse Kern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilse Kern. The network helps show where Ilse Kern may publish in the future.

Co-authorship network of co-authors of Ilse Kern

This figure shows the co-authorship network connecting the top 25 collaborators of Ilse Kern. A scholar is included among the top collaborators of Ilse Kern based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ilse Kern. Ilse Kern is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Altomare, Daniele, Federica Ribaldi, Szymon Tomczyk, et al.. (2023). Plasma biomarkers for Alzheimer’s disease: a field-test in a memory clinic. Journal of Neurology Neurosurgery & Psychiatry. 94(6). 420–427. 39 indexed citations
2.
Lebigot, Élise, Emmanuel Roze, Claude Cancés, et al.. (2022). Movement disorders in valine métabolism diseases caused by HIBCH and ECHS1 deficiencies. European Journal of Neurology. 29(11). 3229–3242. 11 indexed citations
3.
Tessitore, Elena, Kevin Dobretz, Nasser A. Dhayat, et al.. (2021). Changes of lipoprotein(a) levels with endogenous steroid hormones. European Journal of Clinical Investigation. 52(2). e13699–e13699. 1 indexed citations
4.
Gencer, Bariş, Fabio Rigamonti, David Nanchen, et al.. (2019). Prognostic value of elevated lipoprotein(a) in patients with acute coronary syndromes. European Journal of Clinical Investigation. 49(7). e13117–e13117. 26 indexed citations
5.
Allali, Gilles, Ilse Kern, Magali Laidet, Stéphane Armand, & Frédéric Assal. (2018). Parkinsonism is a Phenotypical Signature of Amyloidopathy in Patients with Gait Disorders. Journal of Alzheimer s Disease. 63(4). 1373–1381. 3 indexed citations
6.
Ranza, Emmanuelle, Konstantinos Varvagiannis, Michel Guipponi, et al.. (2017). SERPINI1 pathogenic variants: An emerging cause of childhood‐onset progressive myoclonic epilepsy. American Journal of Medical Genetics Part A. 173(9). 2456–2460. 9 indexed citations
7.
Tran, Christel, Jacques Serratrice, Jean‐Marc Nuoffer, et al.. (2017). Raising the internist's know-how in the field of rare diseases: mitochondrial diseases as an illustrative example. PubMed. 13(546). 159–163. 1 indexed citations
8.
Colaianna, Marilena, Sten Ilmjärv, Hedi Peterson, et al.. (2016). Fingerprinting of neurotoxic compounds using a mouse embryonic stem cell dual luminescence reporter assay. Archives of Toxicology. 91(1). 365–391. 8 indexed citations
9.
Pittet, Mikäel J., Ilse Kern, Nils Guinand, et al.. (2016). Acute cortical deafness in a child with MELAS syndrome. Journal of Inherited Metabolic Disease. 39(3). 465–466. 6 indexed citations
10.
Tran, Christel, Frédéric Barbey, Luisa Bonafé, Nelly Pitteloud, & Ilse Kern. (2015). [b]Erreurs[/b] innées du métabolisme : transition enfant-adulte. Revue Médicale Suisse. 11(462). 445–449. 1 indexed citations
11.
Huemer, Martina, Sabine Scholl‐Bürgi, Karine Hadaya, et al.. (2014). Three new cases of late-onset cblC defect and review of the literature illustrating when to consider inborn errors of metabolism beyond infancy. Orphanet Journal of Rare Diseases. 9(1). 161–161. 75 indexed citations
12.
Keil, Stefanie, Francjan J. van Spronsen, Nilo Lambruschini, et al.. (2013). Long-term Follow-up and Outcome of Phenylketonuria Patients on Sapropterin: A Retrospective Study. PEDIATRICS. 131(6). e1881–e1888. 61 indexed citations
13.
Fluss, Joël, et al.. (2013). Positive Outcome following Early Diagnosis and Treatment of Pyridoxal-5′-Phosphate Oxidase Deficiency: A Case Report. Neuropediatrics. 45(1). 64–68. 23 indexed citations
14.
Fluss, Joël, et al.. (2012). Vitamin D deficiency: A forgotten treatable cause of motor delay and proximal myopathy. Brain and Development. 36(1). 84–87. 13 indexed citations
15.
Schaller, André, Dagmar Hahn, Christopher B. Jackson, et al.. (2011). Molecular and biochemical characterisation of a novel mutation in POLGassociated with Alpers syndrome. BMC Neurology. 11(1). 4–4. 29 indexed citations
16.
Kern, Ilse, Michel F. Rossier, & Pierre O. Chappuis. (2007). Epigénétique et cancer. Revue Médicale Suisse. 3(100). 540–545. 1 indexed citations
17.
Spahr, Laurent, Solange Bresson‐Hadni, Ilse Kern, et al.. (2006). Allopurinol, oxidative stress and intestinal permeability in patients with cirrhosis: an open‐label pilot study. Liver International. 27(1). 54–60. 40 indexed citations
18.
Opladen, Thomas, et al.. (2005). Severe mucitis after sublingual administration of tetrahydrobiopterin in a patient with tetrahydrobiopterin-responsive phenylketonuria. European Journal of Pediatrics. 164(6). 395–396. 2 indexed citations
19.
Kern, Ilse, Viktor Steimle, Claire‐Anne Siegrist, & Bernard Mach. (1995). The two novel MHC class II transactivators RFX5 and CIITA both control expression of HLA-DM genes. International Immunology. 7(8). 1295–1299. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026